NO20040011L - DNA-sekvenser med gentranskripsjonsregulatoriske egenskaper samt fremgangsmater ved pavisning og anvendelse av slike DNA-sekvenser - Google Patents

DNA-sekvenser med gentranskripsjonsregulatoriske egenskaper samt fremgangsmater ved pavisning og anvendelse av slike DNA-sekvenser

Info

Publication number
NO20040011L
NO20040011L NO20040011A NO20040011A NO20040011L NO 20040011 L NO20040011 L NO 20040011L NO 20040011 A NO20040011 A NO 20040011A NO 20040011 A NO20040011 A NO 20040011A NO 20040011 L NO20040011 L NO 20040011L
Authority
NO
Norway
Prior art keywords
dna sequences
staining
methods
well
transcriptional regulatory
Prior art date
Application number
NO20040011A
Other languages
English (en)
Other versions
NO338477B1 (no
Inventor
Arie Peter Otte
Arthur Leo Kruckeberg
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01202581A external-priority patent/EP1273666A1/en
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Publication of NO20040011L publication Critical patent/NO20040011L/no
Publication of NO338477B1 publication Critical patent/NO338477B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Det beskrives en systematisk belysning og identifikasjon av regulatoriske sekvenser.Bl.a. tilveiebringes test- og påvisningsmetoder som kan brukes til å identifisere regulatoriske sekvenser. Videre tilveiebringes regulatoriske sekvenser og anvendelse derav innen forskjellige felter, omfattende, men ikke begrenset til, proteinproduksjon, diagnostisering, transgene planter og dyr, samt det terapeutiske felt.
NO20040011A 2001-07-04 2004-01-02 DNA-sekvenser med gentranskripsjonsregulatoriske egenskaper samt fremgangsmåter ved påvisning og anvendelse av slike DNA-sekvenser NO338477B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP01202581A EP1273666A1 (en) 2001-07-04 2001-07-04 Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
US30319901P 2001-07-05 2001-07-05
PCT/NL2002/000390 WO2003004704A2 (en) 2001-07-04 2002-06-14 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
US10/190,312 US7192741B2 (en) 2001-07-04 2002-07-05 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences

Publications (2)

Publication Number Publication Date
NO20040011L true NO20040011L (no) 2004-03-03
NO338477B1 NO338477B1 (no) 2016-08-22

Family

ID=47915807

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040011A NO338477B1 (no) 2001-07-04 2004-01-02 DNA-sekvenser med gentranskripsjonsregulatoriske egenskaper samt fremgangsmåter ved påvisning og anvendelse av slike DNA-sekvenser

Country Status (21)

Country Link
US (9) US7192741B2 (no)
EP (8) EP1806407B1 (no)
JP (3) JP4500044B2 (no)
KR (2) KR100942116B1 (no)
CN (1) CN1266282C (no)
AT (8) ATE358183T1 (no)
AU (3) AU2002314629B2 (no)
BR (1) BRPI0210771B8 (no)
CA (2) CA2450020C (no)
CY (1) CY1107678T1 (no)
DE (8) DE60237048D1 (no)
DK (8) DK1829972T3 (no)
ES (8) ES2344072T3 (no)
IL (4) IL159674A0 (no)
MX (1) MXPA03011801A (no)
NO (1) NO338477B1 (no)
NZ (1) NZ530218A (no)
PT (1) PT1600510E (no)
SG (1) SG143066A1 (no)
WO (1) WO2003004704A2 (no)
ZA (1) ZA200309599B (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1806407B1 (en) 2001-07-04 2010-05-05 Chromagenics B.V. DNA sequences having anti-repressor activity
EP1513936A2 (en) 2002-06-14 2005-03-16 Chromagenics B.V. Use of repression blocking sequences in methods for enhancing gene expression
DK1513937T3 (da) 2002-06-14 2011-05-16 Chromagenics Bv Fremgangsmåde til den samtidige produktion af multiple proteiner; vektorer og celler til anvendelse derved
EP2314629B2 (en) 2002-07-18 2022-11-16 Merus N.V. Recombinant production of mixtures of antibodies
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
CA2510179C (en) 2002-12-18 2013-04-23 Chromagenics B.V. A method for improving protein production
ATE354645T1 (de) 2002-12-20 2007-03-15 Chromagenics Bv Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
WO2004106375A1 (en) 2003-05-30 2004-12-09 Merus Biopharmaceuticals B.V. I.O. Fab library for the preparation of anti vegf and anti rabies virus fabs
KR101203817B1 (ko) 2003-10-02 2012-11-23 크루셀 홀란드 비.브이. 재조합 아데노바이러스를 위한 포장 세포
WO2005059149A2 (en) * 2003-12-12 2005-06-30 Chromagenics B.V. Improved protein production
AU2005205412B2 (en) 2004-01-20 2011-08-11 Merus N.V. Mixtures of binding proteins
WO2006005718A2 (en) * 2004-07-08 2006-01-19 Chromagenics B.V. Novel sequence for improving expression of nucleic acid
PT1786908E (pt) * 2004-08-18 2010-04-29 Bayer Cropscience Ag Plantas com um aumento da actividade da enzima de fosforilação do amido r3 nos plastídeos
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
PL1809750T3 (pl) 2004-11-08 2012-08-31 Chromagenics Bv Selekcja komórki gospodarza eksprymującej białko na wysokich poziomach
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
CN101090968B (zh) 2004-11-08 2011-10-26 科罗迈吉尼科斯公司 高水平表达蛋白质的宿主细胞的选择
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
CA2587712C (en) * 2004-11-18 2013-02-12 National University Of Corporation Hiroshima University Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant
US7968700B2 (en) 2006-03-20 2011-06-28 Chromagenics B.V. Expression augmenting DNA fragments, use thereof, and methods for finding thereof
US20080124760A1 (en) 2006-07-26 2008-05-29 Barbara Enenkel Regulatory Nucleic Acid Elements
WO2008085956A2 (en) * 2007-01-08 2008-07-17 Millipore Corporation High expression cell line that eliminates gene amplification
EP2443239B1 (en) 2009-06-15 2015-11-25 Cellagenics B.V. Novel stringent selectable markers
US8566596B2 (en) 2010-08-24 2013-10-22 Cisco Technology, Inc. Pre-association mechanism to provide detailed description of wireless services
US9650630B2 (en) 2010-09-01 2017-05-16 Cellagenics B.V. Nucleic acid fragments from a ribosomal protein promoter for enhancing gene expression
DK2838918T3 (da) 2012-04-20 2019-08-12 Merus Nv Fremgangsmåder og midler til fremstilling af heterodimere ig-lignende molekyler
US11180572B2 (en) 2012-07-06 2021-11-23 Genmab B.V. Dimeric protein with triple mutations
PL2900694T3 (pl) 2012-09-27 2018-12-31 Merus N.V. Dwuswoiste przeciwciała igg jako aktywatory komórek t
US10417380B1 (en) 2013-12-31 2019-09-17 Mckesson Corporation Systems and methods for determining and communicating a prescription benefit coverage denial to a prescriber
US10489552B2 (en) 2014-02-14 2019-11-26 Mckesson Corporation Systems and methods for determining and communicating patient incentive information to a prescriber
EP3786186A1 (en) 2014-02-28 2021-03-03 Merus N.V. Antibodies that bind egfr and erbb3
SMT202500020T1 (it) 2014-02-28 2025-03-12 Merus Nv Anticorpo che lega erbb-2 ed erbb-3
US10157262B1 (en) 2015-03-10 2018-12-18 Mckesson Corporation Systems and methods for determining patient financial responsibility for multiple prescription products
AU2016293942B2 (en) 2015-07-10 2022-06-16 Merus B.V. Human CD3 binding antibody
WO2017069628A2 (en) 2015-10-23 2017-04-27 Merus N.V. Binding molecules that inhibit cancer growth
US11514137B1 (en) 2016-03-30 2022-11-29 Mckesson Corporation Alternative therapy identification system
US10999224B1 (en) 2017-02-01 2021-05-04 Mckesson Corporation Method and apparatus for parsing an electronic message and constructing multiple differently prioritized messages therefrom
US11780925B2 (en) 2017-03-31 2023-10-10 Merus N.V. ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene
US12195551B2 (en) 2017-05-17 2025-01-14 Merus N.V. Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancer
SI3665198T1 (sl) 2017-08-09 2025-06-30 Merus N.V. Protitelesa, ki vežejo egfr in cmet
US10862832B1 (en) 2018-07-24 2020-12-08 Mckesson Corporation Computing system and method for automatically reversing an action indicated by an electronic message
US11043437B2 (en) 2019-01-07 2021-06-22 Applied Materials, Inc. Transparent substrate with light blocking edge exclusion zone
US12525327B1 (en) 2019-06-26 2026-01-13 Mckesson Corporation Method, apparatus, and computer program product for providing real-time pricing information
US11562437B1 (en) 2019-06-26 2023-01-24 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
US11636548B1 (en) 2019-06-26 2023-04-25 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
US12469040B1 (en) 2019-06-26 2025-11-11 Mckesson Corporation Method, apparatus, and computer program product for providing real-time pricing information
EP3772518A1 (en) 2019-08-07 2021-02-10 Merus N.V. Modified human variable domains
WO2021155369A1 (en) * 2020-01-31 2021-08-05 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods to identify genetic silencers and applications thereof
US11610240B1 (en) 2020-02-17 2023-03-21 Mckesson Corporation Method, apparatus, and computer program product for partitioning prescription transaction costs in an electronic prescription transaction
US12229834B1 (en) 2020-02-17 2025-02-18 Mckesson Corporation Method, apparatus, and computer program product for partitioning prescription transaction costs in an electronic prescription transaction
US12229833B1 (en) 2020-02-17 2025-02-18 Mckesson Corporation Method, apparatus, and computer program product for reformatting an electronic prescription transaction
KR20230013030A (ko) 2020-05-21 2023-01-26 메뤼스 엔.페. Ig-유사 분자의 생산을 위한 방법 및 수단
US11587657B2 (en) 2020-09-04 2023-02-21 Mckesson Corporation Method, apparatus, and computer program product for performing an alternative evaluation procedure in response to an electronic message
US12367954B1 (en) 2021-01-08 2025-07-22 Mckesson Corporation Method, apparatus, and computer program product for estimating a target quantitative measure based upon historical electronic messages
US12518304B1 (en) 2021-01-26 2026-01-06 Mckesson Corporation Method, apparatus, and computer program product for estimating a target quantitative measure based upon historical electronic messages
CN113539357B (zh) * 2021-06-10 2024-04-30 阿里巴巴达摩院(杭州)科技有限公司 基因检测方法、模型训练方法、装置、设备及系统
US12197972B1 (en) 2022-03-28 2025-01-14 Mckesson Corporation Method, apparatus, and computer program product for generating alternative evaluation messages

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US719271A (en) * 1902-01-13 1903-01-27 Solomon P Smith Furnace.
US5610053A (en) 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
US5972605A (en) * 1994-07-07 1999-10-26 Geron Corporation Assays for regulators of mammalian telomerase expression
AU699275B2 (en) * 1995-03-24 1998-11-26 Shionogi & Co., Ltd. DNA molecule relating to suppression of gene expression and novel protein
DE19539493A1 (de) * 1995-10-24 1997-04-30 Thomae Gmbh Dr K Starker homologer Promotor aus Hamster
US5773695A (en) 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
US6037525A (en) * 1996-08-01 2000-03-14 North Carolina State University Method for reducing expression variability of transgenes in plant cells
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
CN100365127C (zh) 1998-07-21 2008-01-30 密理博公司 具有遍在染色质开放表达元件(ucoe)的聚核苷酸
DK1104490T3 (da) 1998-08-14 2008-01-02 Chromagenics Bv Fremgangsmåde til påvisning af en DNA-sekvens, DNA-sekvens, fremgangsmåde til fremstilling af en DNA-konstruktion samt anvendelse deraf
US6521419B1 (en) 1998-09-22 2003-02-18 Kanakaraju Koduri Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6800457B2 (en) 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
AU1128400A (en) 1998-10-22 2000-05-08 Medical College Of Georgia Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
US6413744B1 (en) * 1999-08-25 2002-07-02 Immunex Corporation Methods and host cells for improved cell culture
US20030166042A1 (en) 2000-02-11 2003-09-04 Millennium Pharmaceuticals, Inc. Novel seven-transmembrane proteins/G-protein coupled receptors
US6586205B1 (en) 2000-02-11 2003-07-01 Millennium Pharmaceuticals, Inc. 43239 a novel GPCR-like molecule and uses thereof
AU9006701A (en) 2000-09-20 2002-04-02 Cobra Therapeutics Ltd Polynucleotide
EP1273666A1 (en) 2001-07-04 2003-01-08 Chromagenics B.V. Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
EP1806407B1 (en) 2001-07-04 2010-05-05 Chromagenics B.V. DNA sequences having anti-repressor activity
DK1513937T3 (da) * 2002-06-14 2011-05-16 Chromagenics Bv Fremgangsmåde til den samtidige produktion af multiple proteiner; vektorer og celler til anvendelse derved
EP1513936A2 (en) * 2002-06-14 2005-03-16 Chromagenics B.V. Use of repression blocking sequences in methods for enhancing gene expression
CA2510179C (en) 2002-12-18 2013-04-23 Chromagenics B.V. A method for improving protein production
ATE354645T1 (de) 2002-12-20 2007-03-15 Chromagenics Bv Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können

Also Published As

Publication number Publication date
AU2002314629B2 (en) 2007-08-30
ATE466944T1 (de) 2010-05-15
DK1845162T3 (da) 2010-08-16
EP1806407A2 (en) 2007-07-11
US20070031933A1 (en) 2007-02-08
US20070031935A1 (en) 2007-02-08
SG143066A1 (en) 2008-06-27
CA2450020A1 (en) 2003-01-16
BR0210771A (pt) 2004-07-13
EP1806407A3 (en) 2008-06-04
EP1600510A2 (en) 2005-11-30
DE60236379D1 (de) 2010-06-24
EP1404872B1 (en) 2006-10-18
AU2011202193A1 (en) 2011-06-02
NO338477B1 (no) 2016-08-22
BRPI0210771B8 (pt) 2021-05-25
US20070128717A1 (en) 2007-06-07
ES2344072T3 (es) 2010-08-17
US7749733B2 (en) 2010-07-06
US7951586B2 (en) 2011-05-31
KR20090037485A (ko) 2009-04-15
US7736869B2 (en) 2010-06-15
DK1808488T3 (da) 2010-10-18
US20070026498A1 (en) 2007-02-01
US7655441B2 (en) 2010-02-02
ES2344074T3 (es) 2010-08-17
IL193374A (en) 2010-12-30
US20070031934A1 (en) 2007-02-08
EP1842919B1 (en) 2010-05-05
EP1829972A3 (en) 2007-10-24
US7736870B2 (en) 2010-06-15
DE60219221T2 (de) 2008-01-03
DE60236333D1 (de) 2010-06-17
ZA200309599B (en) 2006-05-31
US20070037256A1 (en) 2007-02-15
JP5014444B2 (ja) 2012-08-29
EP1808488B1 (en) 2010-07-14
CA2812799C (en) 2016-01-26
EP1845162B1 (en) 2010-05-05
BRPI0210771B1 (pt) 2015-12-22
ATE467682T1 (de) 2010-05-15
KR20090037960A (ko) 2009-04-16
EP1829972A2 (en) 2007-09-05
EP1829971A1 (en) 2007-09-05
DE60237048D1 (de) 2010-08-26
CA2450020C (en) 2013-08-13
US20030199468A1 (en) 2003-10-23
IL193373A (en) 2010-12-30
DE60236332D1 (de) 2010-06-17
HK1068652A1 (en) 2005-04-29
ES2348174T3 (es) 2010-11-30
US7192741B2 (en) 2007-03-20
PT1600510E (pt) 2007-06-25
JP2004533262A (ja) 2004-11-04
ES2274045T3 (es) 2007-05-16
EP1829971A3 (en) 2008-06-04
US20070026499A1 (en) 2007-02-01
ATE466942T1 (de) 2010-05-15
CA2812799A1 (en) 2003-01-16
EP1600510B1 (en) 2007-03-28
EP1806407B1 (en) 2010-05-05
EP1829971B1 (en) 2010-05-05
AU2007234619B2 (en) 2011-06-02
JP2010131024A (ja) 2010-06-17
KR100942116B1 (ko) 2010-02-12
DK1842919T3 (da) 2010-08-16
DK1829972T3 (da) 2010-09-13
ATE474053T1 (de) 2010-07-15
AU2011202193B2 (en) 2011-09-29
ATE358183T1 (de) 2007-04-15
DE60236334D1 (de) 2010-06-17
IL159674A0 (en) 2004-06-20
JP2010131025A (ja) 2010-06-17
ATE466943T1 (de) 2010-05-15
DE60219221D1 (de) 2007-05-10
CN1524128A (zh) 2004-08-25
EP1600510A3 (en) 2006-02-22
EP1845162A1 (en) 2007-10-17
DK1829971T3 (da) 2010-08-16
JP5014443B2 (ja) 2012-08-29
US7662591B2 (en) 2010-02-16
WO2003004704A2 (en) 2003-01-16
ATE466941T1 (de) 2010-05-15
KR100942117B1 (ko) 2010-02-12
CN1266282C (zh) 2006-07-26
ES2344071T3 (es) 2010-08-17
EP1829972B1 (en) 2010-05-12
EP1842919A1 (en) 2007-10-10
ES2344070T3 (es) 2010-08-17
DK1806407T3 (da) 2010-08-16
US7659094B2 (en) 2010-02-09
US20070031936A1 (en) 2007-02-08
ES2285630T3 (es) 2007-11-16
AU2007234619A1 (en) 2007-12-13
ATE343004T1 (de) 2006-11-15
JP4500044B2 (ja) 2010-07-14
DK1404872T3 (da) 2007-02-19
MXPA03011801A (es) 2005-03-07
DE60236331D1 (de) 2010-06-17
WO2003004704A3 (en) 2003-10-16
US7736868B2 (en) 2010-06-15
EP1808488A2 (en) 2007-07-18
ES2344073T3 (es) 2010-08-17
DK1600510T3 (da) 2007-06-25
DE60215502T2 (de) 2007-08-30
EP1404872A2 (en) 2004-04-07
DE60215502D1 (de) 2006-11-30
EP1808488A3 (en) 2007-11-14
IL159674A (en) 2009-02-11
CY1107678T1 (el) 2013-04-18
NZ530218A (en) 2005-09-30

Similar Documents

Publication Publication Date Title
SG143066A1 (en) Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences
PT1202743E (pt) Composicoes farmaceuticas e cosmeticas compreendendo serina-proteases de bacalhau e sua utilizacao farmaceutica e cosmetica
ATE333517T1 (de) Verfahren und sondenset zur erkennung von krebs
EP1750771A4 (en) PANCREAS MICRO RNA AND METHOD OF SUPPRESSING IT
ATE330038T1 (de) Nukleinsäure-biosensor
WO2005019470A3 (en) Detecting and profiling molecular complexes
TR200003159T2 (tr) Antipicornaviral bileşikler, hazırlanışları ve kullanımları
WO2006028601A3 (en) Method for distinguishing methicillin resistant s. aureus from methicillin sensitive s. aureus in a mixed culture
TR200200693T2 (tr) Gen ifadesinin kontrolü için bitkisel düzenleyici sekanslar
WO2002077176A3 (en) Aberrantly expressed proteins in laser capture microdissected tumors
HRP20080069T3 (en) Avian e. coli vaccine for the protection against colibacillosis
DE60111620D1 (de) Aktiviertes protein c zur behandlung von pankreatitis
DE69913325D1 (de) Nephrin gen und protein
EP1573023A4 (en) NUCLEIC ACID AND CORRESPONDING PROTEIN NAMES 162P1E6 USEFUL IN THE DETECTION AND TREATMENT OF CANCER
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
ATE230761T1 (de) Monoklonale antikörper gegen einen komplex aus humanem act und einer serinprotease
DE60039453D1 (de) Pin1 als stadiumsmarker der aggressivität und/oder der metastasierung abnormale zellwachstum
ATE467123T1 (de) Verfahren zum identifizieren biologisch aktiver mittel und synergistischer kombinationen
DK1250449T3 (da) Fremgangsmåde til identifikation af evolutionært signifikante ændringer i polynucleotid- og polypeptidsekvenser hos domesticerede planter og dyr
FR2883298B1 (fr) Fragments d'acides nucleiques et methode de detection specifique par identification moleculaire de differentes especes de bacteries du genre acinetobacter
CN110373490A (zh) 一种快速鉴定刺苍耳的引物及试剂盒
ATE538201T1 (de) Kcnb: ein kaliumkanalprotein
DE602004026838D1 (de) Eine metacaspasen-klasse
Spence et al. Checkmate: A master strategy for securing your water treatment facility
DK1272663T3 (da) Polymorfier i det humane CYP2B6-gen og deres anvendelse ved diagnostiske og terapeutiske anvendelser

Legal Events

Date Code Title Description
MK1K Patent expired